White & Case and Osler, Hoskin & Harcourt LLP advised Inversago Pharma Inc. on the deal, while Wilson Sonsini advised NEA. Inversago Pharma Inc., a clinical-stage...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented New Enterprise Associates (NEA) on the deal. New Enterprise Associates (NEA) acted as the lead investor in the $4.2 million funding...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised AI Squared on the deal while Foley & Lardner LLP represented NEA. AI Squared announced its $6 million Series...
You must be a Standard 1 Year member to access this content.
Morrison Foerster advised New Enterprise Associates, 4BIO Capital, and UPMC Enterprises on the deal. New Enterprise Associates, 4BIO Capital, and UPMC Enterprises acted as investors in...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented New Enterprise Associates on the deal. New Enterprise Associates (NEA) announced its investment in the $18 million Series A financing round...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised New Enterprise Associates, Inc. (NEA) on the deal. New Enterprise Associates, Inc. (NEA) acted as lead investor in Datafold’s $20 million Series...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised New Enterprise Associates on the deal. New Enterprise Associates (NEA), a global venture capital firm acted as lead investors in the $45 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised New Enterprise Associates (NEA) and Versant Ventures on the deal. 858 Therapeutics announced the completion of a $60 million Series...
You must be a Standard 1 Year member to access this content.
Crowell & Moring LLP advised FightCamp on the deal while Foley & Lardner LLP represented New Enterprise Associates (NEA) and Connect Ventures as lead investor. FightCamp,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Versant Ventures and NEA on the deal. Stablix Therapeutics announced a $63 million Series A financing. The funding round was...
You must be a Standard 1 Year member to access this content.
